A FINEH Protein Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-31

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this trial are to assess the health benefits of acute hemp protein consumption compared to soybean protein and a non-protein control on: 1) blood glucose, appetite and blood pressure for one hour following consumption, 2) food intake at an ad libitum meal one hour following consumption and 3) blood glucose, appetite and blood pressure following the ad libitum meal to determine the "second meal effect" of hemp protein.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Benefits of Hemp Protein Supplementation During Resistance Training

NCT02529917

Sarcopenia

COMPLETED NA

Safety Evaluation of THC-Free Hemp Protein Isolate

NCT07022275

Tolerability of Hemp Protein

ACTIVE_NOT_RECRUITING NA

PERFECT Project - Part 1 - Study 1

NCT02402504

Diabetes Prevention Obesity Prevention

COMPLETED NA

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I

NCT03669796

Healthy Volunteers

COMPLETED NA

The Effect of a High Protein, High Fibre Shake Pre-load on Measures of Satiety and Subsequent Energy Intake

NCT02979717

Overweight and Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Prevention Obesity Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

20g Hemp protein shake

Hemp protein shake, 20 grams, given once at beginning of acute trial

Group Type EXPERIMENTAL

Hemp shake

Intervention Type OTHER

Hemp protein shake

40 g hemp protein shake

Hemp protein shake, 40 grams, given once, at beginning of acute trial

Group Type EXPERIMENTAL

Hemp shake

Intervention Type OTHER

Hemp protein shake

20 g Soybean protein shake

Soybean protein shake, 20 grams, given once, at beginning of acute trial

Group Type ACTIVE_COMPARATOR

Soybean shake

Intervention Type OTHER

Soybean protein shake

40 g Soybean protein shake

Soybean protein shake, 40 grams, given once, at beginning of acute trial

Group Type EXPERIMENTAL

Soybean shake

Intervention Type OTHER

Soybean protein shake

Control shake

non-protein control shake, given once, at beginning of acute trial

Group Type PLACEBO_COMPARATOR

Control

Intervention Type OTHER

Non-protein shake

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hemp shake

Hemp protein shake

Intervention Type OTHER

Soybean shake

Soybean protein shake

Intervention Type OTHER

Control

Non-protein shake

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normoglycemic (\<5.6 mmol/L)
* Body mass index (BMI) of 18.5-29.9 kg/m2 Participants will be excluded if they regularly skip breakfast, smoke, or consuming medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.

Exclusion Criteria

* Restrained eaters
* Regularly skip breakfast
* Smokers
* Those who are active (organized activities or athletic training at a high intensity; ≥ 150 min per week of moderate to vigorous physical activity)
* Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes